Cargando…

Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series

OBJECTIVE: To study the clinical characteristics of patients in Zhejiang province, China, infected with the 2019 severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) responsible for coronavirus disease 2019 (covid-2019). DESIGN: Retrospective case series. SETTING: Seven hospitals in Zhejiang...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xiao-Wei, Wu, Xiao-Xin, Jiang, Xian-Gao, Xu, Kai-Jin, Ying, Ling-Jun, Ma, Chun-Lian, Li, Shi-Bo, Wang, Hua-Ying, Zhang, Sheng, Gao, Hai-Nv, Sheng, Ji-Fang, Cai, Hong-Liu, Qiu, Yun-Qing, Li, Lan-Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224340/
https://www.ncbi.nlm.nih.gov/pubmed/32075786
http://dx.doi.org/10.1136/bmj.m606
_version_ 1783533882150223872
author Xu, Xiao-Wei
Wu, Xiao-Xin
Jiang, Xian-Gao
Xu, Kai-Jin
Ying, Ling-Jun
Ma, Chun-Lian
Li, Shi-Bo
Wang, Hua-Ying
Zhang, Sheng
Gao, Hai-Nv
Sheng, Ji-Fang
Cai, Hong-Liu
Qiu, Yun-Qing
Li, Lan-Juan
author_facet Xu, Xiao-Wei
Wu, Xiao-Xin
Jiang, Xian-Gao
Xu, Kai-Jin
Ying, Ling-Jun
Ma, Chun-Lian
Li, Shi-Bo
Wang, Hua-Ying
Zhang, Sheng
Gao, Hai-Nv
Sheng, Ji-Fang
Cai, Hong-Liu
Qiu, Yun-Qing
Li, Lan-Juan
author_sort Xu, Xiao-Wei
collection PubMed
description OBJECTIVE: To study the clinical characteristics of patients in Zhejiang province, China, infected with the 2019 severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) responsible for coronavirus disease 2019 (covid-2019). DESIGN: Retrospective case series. SETTING: Seven hospitals in Zhejiang province, China. PARTICIPANTS: 62 patients admitted to hospital with laboratory confirmed SARS-Cov-2 infection. Data were collected from 10 January 2020 to 26 January 2020. MAIN OUTCOME MEASURES: Clinical data, collected using a standardised case report form, such as temperature, history of exposure, incubation period. If information was not clear, the working group in Hangzhou contacted the doctor responsible for treating the patient for clarification. RESULTS: Of the 62 patients studied (median age 41 years), only one was admitted to an intensive care unit, and no patients died during the study. According to research, none of the infected patients in Zhejiang province were ever exposed to the Huanan seafood market, the original source of the virus; all studied cases were infected by human to human transmission. The most common symptoms at onset of illness were fever in 48 (77%) patients, cough in 50 (81%), expectoration in 35 (56%), headache in 21 (34%), myalgia or fatigue in 32 (52%), diarrhoea in 3 (8%), and haemoptysis in 2 (3%). Only two patients (3%) developed shortness of breath on admission. The median time from exposure to onset of illness was 4 days (interquartile range 3-5 days), and from onset of symptoms to first hospital admission was 2 (1-4) days. CONCLUSION: As of early February 2020, compared with patients initially infected with SARS-Cov-2 in Wuhan, the symptoms of patients in Zhejiang province are relatively mild.
format Online
Article
Text
id pubmed-7224340
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group Ltd.
record_format MEDLINE/PubMed
spelling pubmed-72243402020-05-14 Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series Xu, Xiao-Wei Wu, Xiao-Xin Jiang, Xian-Gao Xu, Kai-Jin Ying, Ling-Jun Ma, Chun-Lian Li, Shi-Bo Wang, Hua-Ying Zhang, Sheng Gao, Hai-Nv Sheng, Ji-Fang Cai, Hong-Liu Qiu, Yun-Qing Li, Lan-Juan BMJ Research OBJECTIVE: To study the clinical characteristics of patients in Zhejiang province, China, infected with the 2019 severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) responsible for coronavirus disease 2019 (covid-2019). DESIGN: Retrospective case series. SETTING: Seven hospitals in Zhejiang province, China. PARTICIPANTS: 62 patients admitted to hospital with laboratory confirmed SARS-Cov-2 infection. Data were collected from 10 January 2020 to 26 January 2020. MAIN OUTCOME MEASURES: Clinical data, collected using a standardised case report form, such as temperature, history of exposure, incubation period. If information was not clear, the working group in Hangzhou contacted the doctor responsible for treating the patient for clarification. RESULTS: Of the 62 patients studied (median age 41 years), only one was admitted to an intensive care unit, and no patients died during the study. According to research, none of the infected patients in Zhejiang province were ever exposed to the Huanan seafood market, the original source of the virus; all studied cases were infected by human to human transmission. The most common symptoms at onset of illness were fever in 48 (77%) patients, cough in 50 (81%), expectoration in 35 (56%), headache in 21 (34%), myalgia or fatigue in 32 (52%), diarrhoea in 3 (8%), and haemoptysis in 2 (3%). Only two patients (3%) developed shortness of breath on admission. The median time from exposure to onset of illness was 4 days (interquartile range 3-5 days), and from onset of symptoms to first hospital admission was 2 (1-4) days. CONCLUSION: As of early February 2020, compared with patients initially infected with SARS-Cov-2 in Wuhan, the symptoms of patients in Zhejiang province are relatively mild. BMJ Publishing Group Ltd. 2020-02-19 /pmc/articles/PMC7224340/ /pubmed/32075786 http://dx.doi.org/10.1136/bmj.m606 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Research
Xu, Xiao-Wei
Wu, Xiao-Xin
Jiang, Xian-Gao
Xu, Kai-Jin
Ying, Ling-Jun
Ma, Chun-Lian
Li, Shi-Bo
Wang, Hua-Ying
Zhang, Sheng
Gao, Hai-Nv
Sheng, Ji-Fang
Cai, Hong-Liu
Qiu, Yun-Qing
Li, Lan-Juan
Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series
title Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series
title_full Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series
title_fullStr Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series
title_full_unstemmed Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series
title_short Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series
title_sort clinical findings in a group of patients infected with the 2019 novel coronavirus (sars-cov-2) outside of wuhan, china: retrospective case series
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224340/
https://www.ncbi.nlm.nih.gov/pubmed/32075786
http://dx.doi.org/10.1136/bmj.m606
work_keys_str_mv AT xuxiaowei clinicalfindingsinagroupofpatientsinfectedwiththe2019novelcoronavirussarscov2outsideofwuhanchinaretrospectivecaseseries
AT wuxiaoxin clinicalfindingsinagroupofpatientsinfectedwiththe2019novelcoronavirussarscov2outsideofwuhanchinaretrospectivecaseseries
AT jiangxiangao clinicalfindingsinagroupofpatientsinfectedwiththe2019novelcoronavirussarscov2outsideofwuhanchinaretrospectivecaseseries
AT xukaijin clinicalfindingsinagroupofpatientsinfectedwiththe2019novelcoronavirussarscov2outsideofwuhanchinaretrospectivecaseseries
AT yinglingjun clinicalfindingsinagroupofpatientsinfectedwiththe2019novelcoronavirussarscov2outsideofwuhanchinaretrospectivecaseseries
AT machunlian clinicalfindingsinagroupofpatientsinfectedwiththe2019novelcoronavirussarscov2outsideofwuhanchinaretrospectivecaseseries
AT lishibo clinicalfindingsinagroupofpatientsinfectedwiththe2019novelcoronavirussarscov2outsideofwuhanchinaretrospectivecaseseries
AT wanghuaying clinicalfindingsinagroupofpatientsinfectedwiththe2019novelcoronavirussarscov2outsideofwuhanchinaretrospectivecaseseries
AT zhangsheng clinicalfindingsinagroupofpatientsinfectedwiththe2019novelcoronavirussarscov2outsideofwuhanchinaretrospectivecaseseries
AT gaohainv clinicalfindingsinagroupofpatientsinfectedwiththe2019novelcoronavirussarscov2outsideofwuhanchinaretrospectivecaseseries
AT shengjifang clinicalfindingsinagroupofpatientsinfectedwiththe2019novelcoronavirussarscov2outsideofwuhanchinaretrospectivecaseseries
AT caihongliu clinicalfindingsinagroupofpatientsinfectedwiththe2019novelcoronavirussarscov2outsideofwuhanchinaretrospectivecaseseries
AT qiuyunqing clinicalfindingsinagroupofpatientsinfectedwiththe2019novelcoronavirussarscov2outsideofwuhanchinaretrospectivecaseseries
AT lilanjuan clinicalfindingsinagroupofpatientsinfectedwiththe2019novelcoronavirussarscov2outsideofwuhanchinaretrospectivecaseseries